IL89569A - Pharmaceutical compositions comprising quinolin-2,5-diones, processes for their preparaion and certain novel compounds - Google Patents
Pharmaceutical compositions comprising quinolin-2,5-diones, processes for their preparaion and certain novel compoundsInfo
- Publication number
- IL89569A IL89569A IL8956989A IL8956989A IL89569A IL 89569 A IL89569 A IL 89569A IL 8956989 A IL8956989 A IL 8956989A IL 8956989 A IL8956989 A IL 8956989A IL 89569 A IL89569 A IL 89569A
- Authority
- IL
- Israel
- Prior art keywords
- group
- hydrogen atom
- methyl
- formula
- quinolinedione
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/22—Oxygen atoms attached in position 2 or 4
- C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
- C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
- C07D221/04—Ortho- or peri-condensed ring systems
- C07D221/06—Ring systems of three rings
- C07D221/10—Aza-phenanthrenes
- C07D221/12—Phenanthridines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
- C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
- C07D221/04—Ortho- or peri-condensed ring systems
- C07D221/06—Ring systems of three rings
- C07D221/16—Ring systems of three rings containing carbocyclic rings other than six-membered
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pain & Pain Management (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Rheumatology (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Quinoline Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE3808136A DE3808136A1 (de) | 1988-03-11 | 1988-03-11 | Arzneimittel, enthaltend chinolin-2,5-dione, neue chinolin-2,5-dione und verfahren zu ihrer herstellung |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL89569A0 IL89569A0 (en) | 1989-09-10 |
| IL89569A true IL89569A (en) | 1994-02-27 |
Family
ID=6349485
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL8956989A IL89569A (en) | 1988-03-11 | 1989-03-10 | Pharmaceutical compositions comprising quinolin-2,5-diones, processes for their preparaion and certain novel compounds |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US5068334A (pt) |
| EP (1) | EP0338228A3 (pt) |
| JP (1) | JPH01299273A (pt) |
| KR (1) | KR890014488A (pt) |
| AU (1) | AU616487B2 (pt) |
| DD (1) | DD283610A5 (pt) |
| DE (1) | DE3808136A1 (pt) |
| DK (1) | DK117389A (pt) |
| FI (1) | FI891154A7 (pt) |
| HU (2) | HU204256B (pt) |
| IL (1) | IL89569A (pt) |
| NO (1) | NO891045L (pt) |
| NZ (1) | NZ228286A (pt) |
| PH (1) | PH27106A (pt) |
| PT (1) | PT89981B (pt) |
| SU (1) | SU1660581A3 (pt) |
| ZA (1) | ZA891798B (pt) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109232416B (zh) * | 2018-10-24 | 2021-09-24 | 福州大学 | 一种合成4-三氟甲基-2-吡喃酮/吡啶酮化合物的方法 |
| CN111978281B (zh) * | 2020-09-02 | 2023-03-28 | 河南师范大学 | 一种制备环己酮/色烯并吡喃酮类化合物的方法及其化合物应用 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS48103590A (pt) * | 1972-04-13 | 1973-12-25 | ||
| JPS51104787A (ja) * | 1975-03-12 | 1976-09-16 | Kyoshi Okano | Nenseiryutaifuiidosochi |
| DE2854498A1 (de) * | 1978-12-16 | 1980-06-26 | Thomae Gmbh Dr K | Neue 7,8-dihydro-2,5(1h,6h)chinolindione, ihre herstellung und ihre verwendung als arzneimittel |
-
1988
- 1988-03-11 DE DE3808136A patent/DE3808136A1/de not_active Withdrawn
-
1989
- 1989-03-06 DD DD89326308A patent/DD283610A5/de not_active IP Right Cessation
- 1989-03-07 EP EP19890103966 patent/EP0338228A3/de not_active Ceased
- 1989-03-09 NZ NZ228286A patent/NZ228286A/en unknown
- 1989-03-09 ZA ZA891798A patent/ZA891798B/xx unknown
- 1989-03-10 PT PT89981A patent/PT89981B/pt not_active IP Right Cessation
- 1989-03-10 FI FI891154A patent/FI891154A7/fi not_active Application Discontinuation
- 1989-03-10 DK DK117389A patent/DK117389A/da not_active Application Discontinuation
- 1989-03-10 NO NO89891045A patent/NO891045L/no unknown
- 1989-03-10 KR KR1019890002943A patent/KR890014488A/ko not_active Withdrawn
- 1989-03-10 HU HU891192A patent/HU204256B/hu not_active IP Right Cessation
- 1989-03-10 SU SU894613665A patent/SU1660581A3/ru active
- 1989-03-10 JP JP1059464A patent/JPH01299273A/ja active Pending
- 1989-03-10 AU AU31188/89A patent/AU616487B2/en not_active Ceased
- 1989-03-10 IL IL8956989A patent/IL89569A/en unknown
- 1989-03-10 HU HU902441A patent/HU205080B/hu not_active IP Right Cessation
- 1989-08-13 PH PH38319A patent/PH27106A/en unknown
- 1989-09-27 US US07/413,369 patent/US5068334A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| US5068334A (en) | 1991-11-26 |
| PH27106A (en) | 1993-03-16 |
| JPH01299273A (ja) | 1989-12-04 |
| ZA891798B (en) | 1990-11-28 |
| HU902441D0 (en) | 1990-08-28 |
| NO891045D0 (no) | 1989-03-10 |
| EP0338228A2 (de) | 1989-10-25 |
| HU204256B (en) | 1991-12-30 |
| NZ228286A (en) | 1990-12-21 |
| DK117389A (da) | 1989-09-12 |
| IL89569A0 (en) | 1989-09-10 |
| AU616487B2 (en) | 1991-10-31 |
| KR890014488A (ko) | 1989-10-24 |
| HU205080B (en) | 1992-03-30 |
| FI891154L (fi) | 1989-09-12 |
| AU3118889A (en) | 1989-09-14 |
| FI891154A7 (fi) | 1989-09-12 |
| PT89981A (pt) | 1989-11-10 |
| PT89981B (pt) | 1994-05-31 |
| SU1660581A3 (ru) | 1991-06-30 |
| DE3808136A1 (de) | 1989-09-21 |
| DD283610A5 (de) | 1990-10-17 |
| NO891045L (no) | 1989-09-12 |
| HUT53084A (en) | 1990-09-28 |
| FI891154A0 (fi) | 1989-03-10 |
| EP0338228A3 (de) | 1991-07-10 |
| DK117389D0 (da) | 1989-03-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69524114T2 (de) | Naphthyridinonderivate | |
| DE69315920T2 (de) | Kondensierte heterozyklische Verbindungen, deren Herstellung und Verwendung | |
| DE3834204C2 (pt) | ||
| KR900007780B1 (ko) | 축합된 피롤리논 유도체의 제조방법 | |
| US4284641A (en) | Pharmaceutically active imidazole derivatives | |
| CS248035B2 (en) | Production method of the(4(oxo-4h)1(-benzopyran-8-yl)carboxyle acides | |
| JPS6136282A (ja) | 窒素を含む複素環式化合物からなる医薬品とその製造方法 | |
| IE59298B1 (en) | Zwitterionic bicyclic compounds and their salts, solvates, hydrates, and esters | |
| US4052508A (en) | Heterocyclic dihydroanthracen imines | |
| Gall et al. | Pharmacology of some metabolites of triazolam, alprazolam, and diazepam prepared by a simple, one-step oxidation of benzodiazepines | |
| US4695581A (en) | 2-(3,5-dialkyl-4-hydroxyphenyl)indole derivatives | |
| US5373015A (en) | Fused pyridine derivatives useful as angiotensin II antagonists | |
| JPH037257A (ja) | ピリジン誘導体及びそれを有効成分とする向精神剤 | |
| US4305954A (en) | Antiinflammatory 3,4-dihydro(or 1,4-dihydro)-2-[(substituted)thio]-[1]benzopyrano[3,4-d]imidazoles and their corresponding sulfoxides and sulfones | |
| DD253821A5 (de) | Verfahren zur herstellung von pyrrolo-benzimidozolen, pyrrolo-benzooxazolen und pyrrolo-benzthiozole | |
| JPH0153266B2 (pt) | ||
| FI66857C (fi) | Foerfarande foer framstaellning av nya farmaceutiskt anvaendbara 3-substituerade dibensofuranderivat | |
| US4053600A (en) | Tricyclic 1,2,4-triazolo-quinazolines | |
| AU616487B2 (en) | Quinolin-2,5-diones | |
| US3467755A (en) | Compositions and methods for producing sedation and tranquilization with substituted 4,5,6,7- tetrahydro-4-oxindoles | |
| US4472408A (en) | Substituted trifluoromethylphenyltetrahydropyridines having an anorectic activity | |
| US4420476A (en) | Benzofuro[3,2-c]pyrazol-3-amine derivatives | |
| US4307102A (en) | Phenanthro[2,3-c]pyrazole | |
| US5114944A (en) | 2-phenylpyrazolo[1,5-a]pyrimidine-3-acetic acid derivatives exhibiting therapeutic effects | |
| CA1177077A (en) | Hexahydro-1,2,4-triazine-3,5 dione derivatives |